The public view is the crawlable proof. The same sourced dataset is available through REST and MCP for agents, research scripts, and back-office tools.
| Date | Insider | Role | Action | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Feb 25, 2026 | TCG Opportunity III GP, LLC | 10% Owner | Sell(S) | 1.6M | $0.56 | $924K |
| Feb 25, 2026 | TCG Opportunity III GP, LLC | 10% Owner | Sell(S) | 1.9M | $0.56 | $1.0M |
| Feb 24, 2026 | TCG Opportunity III GP, LLC | 10% Owner | Sell(S) | 349K | $0.62 | $217K |
| Feb 24, 2026 | TCG Opportunity III GP, LLC | 10% Owner | Sell(S) | 309K | $0.62 | $192K |
| Feb 23, 2026 | Column Group III-A, LP | 10% Owner | Sell(S) | 162K | $0.60 | $97K |
| Feb 23, 2026 | Column Group III-A, LP | 10% Owner | Sell(S) | 144K | $0.60 | $86K |
| Feb 20, 2026 | Column Group III-A, LP | 10% Owner | Sell(S) | 278K | $0.61 | $169K |
| Feb 20, 2026 | Column Group III-A, LP | 10% Owner | Sell(S) | 246K | $0.61 | $150K |
| Feb 17, 2026 | Tingley Whittemore | Chief Medical Officer | Sell(S) | 2K | $0.64 | $1K |
| Feb 17, 2026 | Tingley Whittemore | Chief Medical Officer | Sell(S) | 2K | $0.64 | $1K |
| Feb 17, 2026 | Tingley Whittemore | Chief Medical Officer | Sell(S) | 2K | $0.64 | $1K |
| Feb 17, 2026 | Ali Faraz | Chief Executive Officer, Director | Sell(S) | 5K | $0.64 | $3K |
| Feb 17, 2026 | Ali Faraz | Chief Executive Officer, Director | Sell(S) | 6K | $0.64 | $4K |
| Feb 17, 2026 | Ali Faraz | Chief Executive Officer, Director | Sell(S) | 4K | $0.64 | $3K |
| Feb 17, 2026 | Higa Tomohiro | SVP, Finance | Sell(S) | 836 | $0.64 | $535 |
| Feb 17, 2026 | Higa Tomohiro | SVP, Finance | Sell(S) | 2K | $0.64 | $1K |
| Feb 17, 2026 | Higa Tomohiro | SVP, Finance | Sell(S) | 611 | $0.64 | $391 |
| Feb 11, 2026 | Column Group III-A, LP | 10% Owner | Sell(S) | 2.2M | $0.68 | $1.5M |
| Feb 11, 2026 | Column Group III-A, LP | 10% Owner | Sell(S) | 1.9M | $0.68 | $1.3M |
| Feb 10, 2026 | Column Group III-A, LP | 10% Owner | Sell(S) | 161K | $0.82 | $132K |
| Feb 10, 2026 | Column Group III-A, LP | 10% Owner | Sell(S) | 182K | $0.82 | $149K |
| Feb 3, 2026 | Ali Faraz | Chief Executive Officer, Director | Grant(A) | 159K | — | $0 |
| Feb 3, 2026 | Ali Faraz | Chief Executive Officer, Director | Grant(A) | 952K | — | $0 |
| Feb 3, 2026 | Tingley Whittemore | Chief Medical Officer | Grant(A) | 49K | — | $0 |
| Feb 3, 2026 | Tingley Whittemore | Chief Medical Officer | Grant(A) | 319K | — | $0 |
| Feb 3, 2026 | Higa Tomohiro | SVP, Finance | Grant(A) | 29K | — | $0 |
| Feb 3, 2026 | Higa Tomohiro | SVP, Finance | Grant(A) | 176K | — | $0 |
| Nov 17, 2025 | Ali Faraz | Chief Executive Officer, Director | Sell(S) | 3K | $1.33 | $4K |
| Nov 17, 2025 | Tingley Whittemore | Chief Medical Officer | Sell(S) | 3K | $1.33 | $4K |
| Nov 17, 2025 | Higa Tomohiro | SVP, Finance | Sell(S) | 1K | $1.33 | $2K |
| Aug 18, 2025 | Higa Tomohiro | SVP, Finance | Sell(S) | 2K | $1.25 | $2K |
| Aug 18, 2025 | Higa Tomohiro | SVP, Finance | Sell(S) | 717 | $1.25 | $896 |
| Aug 18, 2025 | Higa Tomohiro | SVP, Finance | Sell(S) | 523 | $1.25 | $654 |
| Aug 18, 2025 | Ali Faraz | Chief Executive Officer, Director | Sell(S) | 6K | $1.25 | $7K |
| Aug 18, 2025 | Ali Faraz | Chief Executive Officer, Director | Sell(S) | 4K | $1.25 | $5K |
| Aug 18, 2025 | Ali Faraz | Chief Executive Officer, Director | Sell(S) | 5K | $1.25 | $6K |
| Aug 18, 2025 | Tingley Whittemore | Chief Medical Officer | Sell(S) | 2K | $1.25 | $2K |
| Aug 18, 2025 | Tingley Whittemore | Chief Medical Officer | Sell(S) | 2K | $1.25 | $2K |
| Aug 18, 2025 | Tingley Whittemore | Chief Medical Officer | Sell(S) | 2K | $1.25 | $2K |
| May 29, 2025 | Parschauer Karah Herdman | Director | Grant(A) | 107K | — | $0 |
| May 29, 2025 | Lee June | Director | Grant(A) | 107K | — | $0 |
| May 29, 2025 | Srivastava Deepak | Director | Grant(A) | 107K | — | $0 |
| May 29, 2025 | Williams R Sanders | Director | Grant(A) | 107K | — | $0 |
| May 29, 2025 | Goeddel David V | Director, 10% Owner | Grant(A) | 107K | — | $0 |
| May 29, 2025 | Burroughs Amy L. | Director | Grant(A) | 107K | — | $0 |
| May 29, 2025 | Walsh Jeffrey T. | Director | Grant(A) | 107K | — | $0 |
| May 29, 2025 | Stehman-Breen Catherine | Director | Grant(A) | 107K | — | $0 |
| May 16, 2025 | Ali Faraz | Chief Executive Officer, Director | Sell(S) | 3K | $0.44 | $1K |
| May 16, 2025 | Tingley Whittemore | Chief Medical Officer | Sell(S) | 3K | $0.44 | $1K |
| May 16, 2025 | Higa Tomohiro | SVP, Finance | Sell(S) | 1K | $0.44 | $612 |
| Mar 10, 2025 | Ali Faraz | Chief Executive Officer, Director | Sell(S) | 4K | $0.54 | $2K |
| Mar 10, 2025 | Ali Faraz | Chief Executive Officer, Director | Sell(S) | 6K | $0.54 | $3K |
| Mar 10, 2025 | Tingley Whittemore | Chief Medical Officer | Sell(S) | 2K | $0.54 | $863 |
| Mar 10, 2025 | Tingley Whittemore | Chief Medical Officer | Sell(S) | 2K | $0.54 | $933 |
| Mar 10, 2025 | Tingley Whittemore | Chief Medical Officer | Sell(S) | 4K | $0.54 | $2K |
| Mar 10, 2025 | Higa Tomohiro | SVP, Finance | Sell(S) | 1K | $0.54 | $549 |
| Mar 10, 2025 | Higa Tomohiro | SVP, Finance | Sell(S) | 845 | $0.54 | $456 |
| Mar 10, 2025 | Higa Tomohiro | SVP, Finance | Sell(S) | 620 | $0.54 | $335 |
| Mar 5, 2025 | Goeddel David V | Director, 10% Owner | Buy(P) | 35.7M | $0.70 | $25.0M |
| Mar 5, 2025 | Goeddel David V | Director, 10% Owner | Buy(P) | 35.7M | — | — |
| Mar 5, 2025 | Goeddel David V | Director, 10% Owner | Buy(P) | 17.9M | — | — |
| Mar 5, 2025 | Column Group III, LP | 10% Owner | Buy(P) | 35.7M | $0.70 | $25.0M |
| Mar 5, 2025 | Column Group III, LP | 10% Owner | Buy(P) | 17.9M | — | — |
| Mar 5, 2025 | Column Group III, LP | 10% Owner | Buy(P) | 35.7M | — | — |
| Feb 6, 2025 | Ali Faraz | Chief Executive Officer, Director | Grant(A) | 108K | — | $0 |
| Feb 6, 2025 | Ali Faraz | Chief Executive Officer, Director | Grant(A) | 34K | — | $0 |
| Feb 6, 2025 | Ali Faraz | Chief Executive Officer, Director | Disposed to issuer(D) | 353K | — | — |
| Feb 6, 2025 | Ali Faraz | Chief Executive Officer, Director | Grant(A) | 401K | — | — |
| Feb 6, 2025 | Ali Faraz | Chief Executive Officer, Director | Disposed to issuer(D) | 401K | — | — |
| Feb 6, 2025 | Ali Faraz | Chief Executive Officer, Director | Grant(A) | 161K | — | — |
| Feb 6, 2025 | Ali Faraz | Chief Executive Officer, Director | Disposed to issuer(D) | 161K | — | — |
| Feb 6, 2025 | Ali Faraz | Chief Executive Officer, Director | Grant(A) | 650K | — | $0 |
| Feb 6, 2025 | Ali Faraz | Chief Executive Officer, Director | Grant(A) | 353K | — | — |
| Jan 24, 2025 | Tingley Whittemore | Chief Medical Officer | Grant(A) | 40K | — | $0 |
| Jan 24, 2025 | Tingley Whittemore | Chief Medical Officer | Grant(A) | 32K | — | $0 |
| Jan 24, 2025 | Tingley Whittemore | Chief Medical Officer | Disposed to issuer(D) | 215K | — | — |
| Jan 24, 2025 | Tingley Whittemore | Chief Medical Officer | Disposed to issuer(D) | 70K | — | — |
| Jan 24, 2025 | Tingley Whittemore | Chief Medical Officer | Grant(A) | 235K | — | $0 |
| Jan 24, 2025 | Tingley Whittemore | Chief Medical Officer | Grant(A) | 205K | — | — |
| Jan 24, 2025 | Tingley Whittemore | Chief Medical Officer | Disposed to issuer(D) | 205K | — | — |
| Jan 24, 2025 | Tingley Whittemore | Chief Medical Officer | Grant(A) | 141K | — | — |
| Jan 24, 2025 | Tingley Whittemore | Chief Medical Officer | Disposed to issuer(D) | 141K | — | — |
| Jan 24, 2025 | Tingley Whittemore | Chief Medical Officer | Grant(A) | 70K | — | — |
| Jan 24, 2025 | Tingley Whittemore | Chief Medical Officer | Grant(A) | 215K | — | — |
| Nov 18, 2024 | Saito Chihiro | SVP, Accounting and Fin. Ops. | Sell(S) | 2K | $2.12 | $5K |
| Oct 18, 2024 | Burroughs Amy L. | Director | Grant(A) | 34K | — | $0 |
| Oct 18, 2024 | Goeddel David V | Director, 10% Owner | Grant(A) | 34K | — | $0 |
| Oct 18, 2024 | Lee June | Director | Grant(A) | 34K | — | $0 |
| Oct 18, 2024 | Parschauer Karah Herdman | Director | Grant(A) | 34K | — | $0 |
| Oct 18, 2024 | Srivastava Deepak | Director | Grant(A) | 34K | — | $0 |
| Oct 18, 2024 | Stehman-Breen Catherine | Director | Grant(A) | 34K | — | $0 |
| Oct 18, 2024 | Williams R Sanders | Director | Grant(A) | 34K | — | $0 |
| Oct 18, 2024 | Walsh Jeffrey T. | Director | Grant(A) | 34K | — | $0 |
| Aug 16, 2024 | Ali Faraz | Chief Executive Officer, Director | Sell(S) | 6K | $2.89 | $17K |
| Aug 16, 2024 | Ali Faraz | Chief Executive Officer, Director | Sell(S) | 4K | $2.89 | $11K |
| Aug 16, 2024 | Tingley Whittemore | Chief Medical Officer | Sell(S) | 2K | $2.89 | $5K |
| Aug 16, 2024 | Tingley Whittemore | Chief Medical Officer | Sell(S) | 6K | $2.89 | $17K |
| Aug 16, 2024 | Saito Chihiro | SVP, Accounting and Fin. Ops. | Sell(S) | 902 | $2.89 | $3K |
| Aug 16, 2024 | Saito Chihiro | SVP, Accounting and Fin. Ops. | Sell(S) | 654 | $2.89 | $2K |
| Aug 16, 2024 | Saito Chihiro | SVP, Accounting and Fin. Ops. | Sell(S) | 807 | $2.89 | $2K |
Insider transactions sourced from SEC EDGAR Form 4 filings, normalized within minutes of acceptance. "Buy"/"Sell" mark open-market transactions (codes P/S), the tradeable signal. Awards, option exercises and tax-withholding are shown with their raw code. All data is public domain.
Programmatic access via the Arkolith API & MCP server (insider.transactions, insider.company).